During the past decade, Norbert Barlicki University Clinical Hospital No.1, Lodz conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Norbert Barlicki University Clinical Hospital No.1, Lodz" #1 collaborator was "Bayer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Norbert Barlicki University Clinical Hospital No.1, Lodz" are "Lung Diseases, Interstitial" (2 trials), "Lupus Nephritis" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials) and "Idiopathic Pulmonary Fibrosis" (1 trials). Many other conditions were trialed in "Norbert Barlicki University Clinical Hospital No.1, Lodz" in a lesser frequency.

Most popular intervention types in "Norbert Barlicki University Clinical Hospital No.1, Lodz" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Interferon beta-1a" (2 trials), "Nintedanib" (2 trials), "Alemtuzumab" (1 trials) and "Alemtuzumab 12 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Norbert Barlicki University Clinical Hospital No.1, Lodz" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Norbert Barlicki University Clinical Hospital No.1, Lodz". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Norbert Barlicki University Clinical Hospital No.1, Lodz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Norbert Barlicki University Clinical Hospital No.1, Lodz, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".